Pre-market Hot Trades in US Stocks

ZeroStack is up 10.91% in pre-market trading. Based on recent key news:

1. On July 9, ZeroStack announced a pharmaceutical distribution order worth $14.7 million. These orders will be executed through its wholly-owned German subsidiary Phatebo GmbH, which is expected to significantly boost the company's revenue. Following the announcement, the stock price surged.

2. On July 9, the company is negotiating with specialized lending institutions to secure inventory financing. This news indicates that the company is likely to smoothly fulfill orders, further enhancing market confidence and driving the stock price up.

3. On July 9, the company issued a statement emphasizing the reliability of its forward-looking statements and stated that it would update information as required by law. This statement helps stabilize investor sentiment and supports the rise in stock price. The pharmaceutical distribution industry has shown strong performance recently, with significant capital inflows.

Broadcom is up 3.57% in pre-market trading. Based on recent key news:

1. On July 6, Broadcom signed a new multi-year cooperation agreement with Apple, extending chip supply cooperation until 2031. This agreement solidifies Broadcom's core position in Apple's supply chain, pushing Broadcom's stock price up about 5% in pre-market trading. Source: Zhitong Finance

2. On July 8, Apple announced a chip supply agreement with Broadcom worth over $30 billion, supporting the production of more than 15 billion chips in the United States. This news further boosted Broadcom's stock price. Source: Wall Street Insight

3. On July 9, the cooperation agreement between Broadcom and Apple is seen as part of Apple's $600 billion investment plan in the United States, causing Broadcom's stock price to rise against the trend, reflecting market confidence in its long-term revenue growth. Source: Jinshi Data AI chip demand growth, optimistic sentiment in tech stocks.

Top Gainers in Pre-market US Stocks

Virax Biolabs is up 151.84% in pre-market trading. Based on recent key news:

1. On July 9, Virax Biolabs Group Ltd. released an announcement detailing the company's performance expectations and risk factors for the future. The announcement mentioned that the company's expectations for future performance are reasonable, but it cannot guarantee that these expectations will be realized. This news triggered a positive market reaction, driving the stock price significantly higher.

2. On July 6, Virax Biolabs Group Ltd. published original content through the EDGAR system of the U.S. Securities and Exchange Commission, detailing the company's financial status and future plans. Investors expressed optimism about the company's prospects, further driving the stock price up.

3. On July 9, Virax Biolabs Group Ltd. detailed risk factors in its annual report. Despite uncertainties, the market remains positive about the company's future performance, leading to a significant rise in stock price. The market holds an optimistic view of the company's future performance, driving the stock price up Lion Group Holding, pre-market up 39.82%, no significant news recently. Trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

EOS ENERGY ENTERPRISES INC COM USD0.0001 CL A (SUB/RT) 21/07/2026, pre-market up 32.00%, no significant news recently. Trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation